Tokyo
Japan
28
2021-06-03
28
2024-03-12
These are the the leading inventors for applications assigned to EISAI R & D Management Co., Ltd.:
EISAI R & D Management Co., Ltd. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Certain pladienolide compounds and methods of use
#2 | 2012-05-24 β Patent 9,968,583 granted on 2018-05-15Method of manufacture of liposome composition
#3 | 2010-07-20 β Patent 7,759,323 granted on 2010-07-20Highly purified antiendotoxin compound
#4 | 2010-06-17 β Patent 8,507,527 granted on 2013-08-13Method for stabilizing anti-dementia drug
#5 | 2009-08-25 β Patent 7,579,325 granted on 2009-08-25Drugs containing reduced of vitamin B
#6 | 2009-06-11 β Patent 8,889,423 granted on 2014-11-18Method for analysis of compound-binding ability of protein
#7 | 2008-11-13 β Patent 7,807,371 granted on 2010-10-05Methods of selecting dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers
#8 | 2008-09-18 β Patent 8,207,144 granted on 2012-06-26Sodium salt of disaccharide compound, production method and use of same
#9 | 2008-09-04 β Patent 7,737,129 granted on 2010-06-15Substituted liposaccharides useful in the treatment and prevention of endotoxemia
#10 | 2008-07-10 β Patent 7,928,209 granted on 2011-04-19Fungal cell wall synthesis gene
#11 | 2008-03-06 β Patent 8,030,083 granted on 2011-10-04Method of analyzing protein structural affinity relationship
#12 | 2007-11-20 β Patent 7,297,773 granted on 2007-11-20Presynaptic protein cast
#13 | 2007-09-20 β Patent 7,538,123 granted on 2009-05-26Indole derivative having piperidine ring
#14 | 2007-07-12 β Patent 7,501,395 granted on 2009-03-10Method of screening for antianxiety drugs
#15 | 2007-07-03 β Patent 7,238,720 granted on 2007-07-03Pharmaceutical use of N-carbamoylazole derivatives
#16 | 2007-06-21 β Patent 7,612,086 granted on 2009-11-03JNK inhibitors
#17 | 2007-06-14 β Patent 7,759,130 granted on 2010-07-20Mass spectrometric quantitation method for biomolecules based on metabolically labeled internal standards
#18 | 2007-04-12 β Patent 7,683,200 granted on 2010-03-23Compounds for preparing immunological adjuvant
#19 | 2007-03-29 β Patent 7,727,974 granted on 2010-06-01Methods of reducing the severity of mucositis
#20 | 2007-02-01 β Patent 7,915,238 granted on 2011-03-29Immunomodulatory compounds and methods of use thereof
#21 | 2006-12-28 β Patent 7,935,526 granted on 2011-05-03hERG channel-expressing cell
#22 | 2006-11-02 β Patent 7,612,092 granted on 2009-11-03Nitrogen-containing aromatic derivatives
#23 | 2006-10-26 β Patent 7,550,503 granted on 2009-06-23Physiologically active substances
#24 | 2006-08-31 β Patent 7,655,800 granted on 2010-02-02Crystalline 1H-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
#25 | 2006-08-03 β Patent 7,608,625 granted on 2009-10-27Method for treating bruxism and bruxism-related diseases
#26 | 2006-07-20 β Patent 7,364,876 granted on 2008-04-29ADIP protein and use thereof
#27 | 2006-01-05 β Patent 7,524,967 granted on 2009-04-28Process for producing 5-(2β²-pyridyl)-2-pyridone derivative
#28 | 2005-11-24 β Patent 7,429,609 granted on 2008-09-30Pyrazole compound and medicinal composition containing the same
405103 β